课题基金 / 基金详情

THE EFFICACY OF LOW DOSE NALTREXONE THERAPY IN CHILDREN WITH CROHN'S

THE EFFICACY OF LOW DOSE NALTREXONE THERAPY IN CHILDREN WITH CROHN'S
低剂量纳曲酮治疗克罗恩病儿童的疗效
批准号:
7951293
负责人:
Jill P Smith
金额:
$1.62万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-04-01 至 2010-03-31

项目摘要

项目成果

Jill P Smith的其他基金

相似基金

相关文献

中文摘要
翻译
这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目及 研究者(PI)可能从另一个NIH来源获得了主要资金, 因此可以在其他CRISP条目中表示。所列机构为 研究中心,而研究中心不一定是研究者的研究机构。 研究人员假设,低剂量纳洛酮治疗对克罗恩病儿童患者有效。为了检验这一假设,他们建议在一项随机双盲安慰剂对照交叉试验中研究低剂量纳洛酮对30例活动性克罗恩病患者的影响。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The investigators hypothesize that low dose naltrexone therapy will be effective in the treatment of pediatric patients with Crohn's disease. In order to examine this hypothesis, they propose to investigate the effects of low dose naltrexone on a cohort of thirty patients with active Crohn's disease in a randomized double-blind placebo controlled cross-over trial.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Phase 1 study to test safety and dose of proglumide as an anti-fibrotic agent
  • 批准号:
    10015244
  • 项目类别:
  • 资助金额:
    $26.25万
  • 财政年份:
    2019
  • 负责人:
    Jill P Smith
  • 依托单位:
Phase 1 study to test safety and dose of proglumide as an anti-fibrotic agent
  • 批准号:
    9808375
  • 项目类别:
  • 资助金额:
    $20.29万
  • 财政年份:
    2019
  • 负责人:
    Jill P Smith
  • 依托单位:
High fat diet stimulates pancreatic cancer through the actions of Cholecystokinin
  • 批准号:
    8969907
  • 项目类别:
  • 资助金额:
    $20.04万
  • 财政年份:
    2015
  • 负责人:
    Jill P Smith
  • 依托单位:
CLINICAL TRIAL: OGF & GEMCITABINE: NOVEL TREATMENT FOR PANCREATIC CANCER
海外基金